|
1
|
PKC-alpha regulates cardiac contractility and propensity toward heart failure.
|
Nat Med
|
2004
|
4.50
|
|
2
|
Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1.
|
Circ Res
|
2005
|
2.52
|
|
3
|
Phosphate incorporation during glycogen synthesis and Lafora disease.
|
Cell Metab
|
2011
|
2.03
|
|
4
|
Type 1 phosphatase, a negative regulator of cardiac function.
|
Mol Cell Biol
|
2002
|
1.97
|
|
5
|
Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest.
|
J Biol Chem
|
2002
|
1.90
|
|
6
|
Structural basis for regulation of protein phosphatase 1 by inhibitor-2.
|
J Biol Chem
|
2007
|
1.74
|
|
7
|
PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease.
|
PLoS Genet
|
2011
|
1.35
|
|
8
|
Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise.
|
J Biol Chem
|
2005
|
1.31
|
|
9
|
Abnormal cardiac development in the absence of heart glycogen.
|
Mol Cell Biol
|
2004
|
1.28
|
|
10
|
Structural basis for glucose-6-phosphate activation of glycogen synthase.
|
Proc Natl Acad Sci U S A
|
2010
|
1.21
|
|
11
|
Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism.
|
J Biol Chem
|
2010
|
1.20
|
|
12
|
Glucose metabolism in mice lacking muscle glycogen synthase.
|
Diabetes
|
2005
|
1.15
|
|
13
|
Phosphorylation of TPX2 by Plx1 enhances activation of Aurora A.
|
Cell Cycle
|
2009
|
1.03
|
|
14
|
Glycogen metabolism in tissues from a mouse model of Lafora disease.
|
Arch Biochem Biophys
|
2006
|
1.00
|
|
15
|
Relationship between glycogen accumulation and the laforin dual specificity phosphatase.
|
Biochem Biophys Res Commun
|
2006
|
0.97
|
|
16
|
A protein phosphatase-1gamma1 isoform selectivity determinant in dendritic spine-associated neurabin.
|
J Biol Chem
|
2004
|
0.93
|
|
17
|
A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice.
|
PLoS Med
|
2008
|
0.91
|
|
18
|
Multiple glycogen-binding sites in eukaryotic glycogen synthase are required for high catalytic efficiency toward glycogen.
|
J Biol Chem
|
2011
|
0.86
|
|
19
|
Basis for MAP4 dephosphorylation-related microtubule network densification in pressure overload cardiac hypertrophy.
|
J Biol Chem
|
2010
|
0.84
|
|
20
|
Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality.
|
Am J Physiol Heart Circ Physiol
|
2008
|
0.84
|
|
21
|
Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1.
|
J Biol Chem
|
2001
|
0.83
|
|
22
|
Protein degradation and quality control in cells from laforin and malin knockout mice.
|
J Biol Chem
|
2014
|
0.81
|
|
23
|
Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase.
|
BMC Neurosci
|
2003
|
0.80
|
|
24
|
Retracted
Epinephrine control of glycogen metabolism in glycogen-associated protein phosphatase PP1G/R(GL) knockout mice.
|
J Biochem Mol Biol
|
2002
|
0.75
|